Natural products of the medicinal fungus Ganoderma lucidum: Occurrence, biological activities, and pharmacological functions
- 30 July 2003
- journal article
- review article
- Published by Wiley in The Chemical Record
- Vol. 3 (3) , 172-180
- https://doi.org/10.1002/tcr.10058
Abstract
Ganoderma lucidum, a fungus used in traditional Chinese medicine, produces polysaccharides and oxygenated triterpenoids with a very broad spectrum of biological activities and pharmacological functions. Among the Ganoderma triterpenoids, many pairs of C‐3 α/β stereoisomers and C‐3/C‐15 positional isomers have been identified. Biosynthetic study has indicated that the C‐3α series of oxygenated triterpenoids is derived from the C‐3β series via an oxidation‐reduction pathway. The interaction of Ganoderma triterpenoids with human platelets in the induction of aggregation and inhibition of agonist‐induced aggregation and signal transduction has been elucidated. Reduction of cellular mevalonate content to a stage in which cholesterol synthesis is strongly inhibited and cell growth is marginally arrested sensitizes hepatoma cells to the oxygenated triterpenoids. A combination treatment of lovastatin and Ganoderma triterpenoids in animal studies has exhibited a potential anticancer effect. © 2003 The Japan Chemical Journal Forum and Wiley Periodicals, Inc., Chem Rec 3: 172–180; 2003: Published online in Wiley InterScience (www.interscience.wiley.com) DOI 10.1002/tcr.10058Keywords
This publication has 55 references indexed in Scilit:
- Activation of human platelet phospholipases C and A2 by various oxygenated triterpenesEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- Ganoderic acid and its derivatives as cholesterol synthesis inhibitors.CHEMICAL & PHARMACEUTICAL BULLETIN, 1989
- Constituents of the fungus Ganoderma lucidum (Fr.) Karst. II Structures of ganoderic acids F, G, and H, lucidenic acids D2 and E2, and related compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I Structures of ganoderic acids C2, E, I, and K, lucidenic acid F and related compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Ganoderic acids T, S and R, new triterpenoids from the cultured mycelia of Ganoderma lucidum.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- Ganoderic acid D, E, F, and H and lucidenic acid D, E, and F, new triterpenoids from Ganoderma lucidum.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes.CHEMICAL & PHARMACEUTICAL BULLETIN, 1985
- Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981